• SIS3 (Smad3 Inhibitor): Precision Tool for Fibrosis Research

  2026-05-20

  SIS3, a highly selective Smad3 inhibitor from APExBIO, enables targeted modulation of the TGF-β signaling pathway, supporting advanced fibrosis and osteoarthritis research. Its robust selectivity and validated in vitro and in vivo efficacy streamline experimental workflows and reveal new mechanistic insights.

• CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E

  2026-05-20

  The referenced study uncovers CLCC1 as an essential host protein for the membrane fusion step of herpesvirus nuclear egress, revealing a previously unknown mechanism critical for viral replication. These findings provide a new cellular target for antiviral research and inform the development of immunomodulatory interventions.

• Exemestane in Translational Breast Cancer: Mechanisms & Stra

  2026-05-19

  This thought-leadership article dissects exemestane’s molecular mechanism as a steroidal aromatase inhibitor and delivers strategic guidance for translational researchers. By integrating recent evidence, competitive landscape analysis, and hands-on workflow advice, we provide a roadmap for leveraging APExBIO’s exemestane in the evolving landscape of breast cancer research. The discussion bridges mechanistic insight with practical protocols and forward-looking perspectives, highlighting how this piece advances beyond conventional product content.

• Senescence Genes as Diagnostic Signatures in Abdominal Aorti

  2026-05-19

  This study pioneers the identification of cellular senescence-associated genes, particularly ETS1 and ITPR3, as robust diagnostic biomarkers for abdominal aortic aneurysm (AAA). By integrating large-scale transcriptomic analyses with machine learning and multi-cohort validation, the research advances early detection strategies and offers insights for targeted therapeutic development.

• Exemestane: Selective Steroidal Aromatase Inhibition in Rese

  2026-05-18

  Exemestane is a potent, selective, and irreversible steroidal aromatase inhibitor. It is widely employed for estrogen biosynthesis inhibition in breast cancer research. This article details its mechanism, evidence basis, and best practices for laboratory use.

• IR-1061 Near Infrared Fluorescent Dye for Deep Tissue Imagin

  2026-05-18

  IR-1061 sets a new benchmark among near infrared fluorescent dyes by enabling high-clarity, deep tissue in vivo imaging with minimal background. Its unique photophysical properties, proven in advanced liposomal encapsulation protocols, empower synergistic imaging-therapy workflows that reimagine molecular imaging in biomedical research.

• Nadolol (SQ-11725) in Advanced Cardiovascular Research Workf

  2026-05-17

  Unlock the experimental potential of Nadolol (SQ-11725) for hypertension, angina pectoris, and vascular headache research. This guide delivers actionable protocols, transporter-focused insights, and troubleshooting solutions—empowering labs to optimize beta-adrenergic signaling studies with APExBIO's rigorously validated compound.

• 3D DNA Frameworks Enhance Enzymatic Oligonucleotide Synthesi

  2026-05-16

  A recent study introduces tetrahedral DNA nanostructures (TDN) as organized scaffolds for enzymatic oligonucleotide synthesis (EOS), significantly improving enzyme accessibility and synthesis fidelity. This innovation enables longer, high-yield DNA synthesis with reduced errors, paving the way for advanced DNA data storage and genetic applications.

• Angiotensin Peptides Facilitate SARS-CoV-2 Spike–AXL Binding

  2026-05-15

  Oliveira et al. (2025) reveal that naturally occurring angiotensin peptides, including truncated forms such as Angiotensin 1/2 (5-7), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor, potentially influencing viral entry in host cells. These findings bridge renin-angiotensin system research with emerging questions in COVID-19 pathogenesis and highlight novel therapeutic targets.

• Angiotensin 1/2 (5-7): Novel Insights for Cardiovascular and

  2026-05-15

  Explore the multifaceted research potential of Angiotensin 1/2 (5-7), a key peptide for RAS and hypertension studies. This article offers new perspectives on assay design, molecular mechanisms, and cross-domain implications for cardiovascular and SARS-CoV-2 research.

• Optimizing Topotecan HCl Workflows as a Topoisomerase 1 Inhi

  2026-05-14

  Leverage Topotecan HCl for advanced, reproducible DNA damage and apoptosis induction in translational tumor models. This guide delivers stepwise workflow enhancements, troubleshooting strategies, and critical protocol parameters to maximize experimental success in antitumor research.

• KU-55933: Potent ATM Kinase Inhibitor for DNA Damage Researc

  2026-05-14

  KU-55933 is a highly selective ATM kinase inhibitor with nanomolar potency, enabling precise interrogation of DNA damage response. This compound suppresses cancer cell proliferation and induces G1 cell cycle arrest, making it a tool of choice in cancer biology and genome stability research. APExBIO supplies KU-55933 (ATM Kinase Inhibitor, SKU A4605) for experimental use only.

• Amorolfine Hydrochloride: Advanced Workflows for Fungal Rese

  2026-05-13

  Amorolfine Hydrochloride, a potent antifungal reagent, is transforming experimental workflows in fungal cell membrane and ploidy research. This article distills protocol enhancements, troubleshooting strategies, and actionable insights—bridging molecular mechanism with breakthrough applications for next-generation antifungal studies.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-05-13

  This paper identifies that naturally occurring angiotensin peptides, including short fragments such as Angiotensin 1/2 (5-7), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings reveal a novel mechanistic link between the renin-angiotensin system and viral entry, informing both cardiovascular and COVID-19 research models.

• Paclitaxel (Taxol) in Combination Nanotherapy: Mechanisms an

  2026-05-12

  Explore the advanced role of Paclitaxel (Taxol) in cancer research, focusing on carrier-free nanoparticle delivery and synergy in hard-to-treat tumors. Uncover new mechanistic insights and assay guidance not found in existing reviews.

16112 records 1/1075 page Next 12345 下5页 Last page